![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07F 5/02 | (2006.01) |
A61P 31/06 | (2006.01) | ||
A61K 31/69 | (2006.01) |
(11) | Number of the document | 3256479 |
(13) | Kind of document | T |
(96) | European patent application number | 16706002.9 |
Date of filing the European patent application | 2016-02-12 | |
(97) | Date of publication of the European application | 2017-12-20 |
(45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
(46) | Date of publication of the claims translation | 2020-12-28 |
(86) | Number | PCT/IB2016/050775 |
Date | 2016-02-12 |
(87) | Number | WO 2016/128948 |
Date | 2016-08-18 |
(30) | Number | Date | Country code |
15382054 | 2015-02-12 | EP | |
15382055 | 2015-02-12 | EP | |
15382056 | 2015-02-12 | EP |
(72) |
ALEMPARTE-GALLARDO, Carlos, ES
ALLEY, M.R.K. (dickon), US
BARROS-AGUIRRE, David, ES
GIORDANO, Ilaria, ES
HERNANDEZ, Vincent, US
LI, Xianfeng, US
PLATTNER, Jacob J., US
|
(73) |
Anacor Pharmaceuticals, Inc.,
1020 East Meadow Circle, Palo Alto, CA 94303,
US
GlaxoSmithKline Intellectual Property (No. 2) Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, GB |
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | 4-Pakeistieji benzoksaborolo junginiai ir jų naudojimas |
4 -SUBSTITUTED BENZOXABOROLE COMPOUNDS AND USES THEREOF |
Payment date | Validity (years) | Amount | |
2025-01-22 | 10 | 231.00 EUR |
2026-02-12 |